SELENOI
Basic information
Region (hg38): 2:26308547-26395885
Previous symbols: [ "EPT1" ]
Links
Phenotypes
GenCC
Source:
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Spastic paraplegia 81, autosomal recessive | AR | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Craniofacial; Neurologic; Ophthalmologic | 28052917; 29500230 |
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the SELENOI gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 7 | |||||
missense | 16 | 17 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 9 | |||||
Total | 0 | 0 | 16 | 4 | 13 |
Variants in SELENOI
This is a list of pathogenic ClinVar variants found in the SELENOI region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
2-26309979-G-A | not specified | Uncertain significance (Sep 11, 2024) | ||
2-26310050-A-G | not specified | Uncertain significance (Sep 26, 2023) | ||
2-26310074-C-T | not specified | Likely benign (Jun 24, 2022) | ||
2-26310084-G-A | not specified | Uncertain significance (Aug 19, 2024) | ||
2-26310090-G-A | not specified | Uncertain significance (Dec 08, 2021) | ||
2-26310718-T-C | not specified | Uncertain significance (Apr 04, 2024) | ||
2-26310730-C-G | not specified | Uncertain significance (Sep 16, 2022) | ||
2-26310732-G-A | not specified | Uncertain significance (Oct 04, 2024) | ||
2-26310817-C-T | not specified | Uncertain significance (Nov 06, 2023) | ||
2-26310844-C-T | not specified | Uncertain significance (Dec 09, 2024) | ||
2-26310850-G-C | not specified | Uncertain significance (Oct 31, 2023) | ||
2-26310889-C-T | not specified | Uncertain significance (Apr 18, 2024) | ||
2-26310913-C-T | not specified | Uncertain significance (Oct 10, 2023) | ||
2-26310937-C-G | not specified | Uncertain significance (Jul 13, 2022) | ||
2-26310988-C-T | not specified | Uncertain significance (Dec 27, 2023) | ||
2-26311018-G-C | not specified | Uncertain significance (Dec 15, 2022) | ||
2-26311030-C-T | Likely benign (Apr 01, 2023) | |||
2-26311086-C-T | not specified | Uncertain significance (Mar 01, 2024) | ||
2-26311117-G-A | not specified | Uncertain significance (Feb 07, 2023) | ||
2-26311194-G-T | not specified | Uncertain significance (Aug 26, 2024) | ||
2-26311219-G-A | Benign (Sep 01, 2022) | |||
2-26311224-C-T | not specified | Uncertain significance (Aug 19, 2024) | ||
2-26311233-A-T | not specified | Uncertain significance (Oct 21, 2024) | ||
2-26311258-T-C | not specified | Uncertain significance (Aug 01, 2024) | ||
2-26311287-T-A | not specified | Uncertain significance (Sep 04, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
SELENOI | protein_coding | protein_coding | ENST00000260585 | 10 | 87345 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.642 | 0.358 | 124629 | 0 | 8 | 124637 | 0.0000321 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.67 | 131 | 197 | 0.665 | 0.00000938 | 2556 |
Missense in Polyphen | 36 | 79.3 | 0.45397 | 1079 | ||
Synonymous | -0.0981 | 77 | 75.9 | 1.01 | 0.00000389 | 768 |
Loss of Function | 3.41 | 4 | 20.8 | 0.193 | 9.68e-7 | 259 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000184 | 0.000184 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.0000469 | 0.0000464 |
European (Non-Finnish) | 0.0000183 | 0.0000177 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Catalyzes phosphatidylethanolamine biosynthesis from CDP-ethanolamine. It thereby plays a central role in the formation and maintenance of vesicular membranes. Involved in the formation of phosphatidylethanolamine via 'Kennedy' pathway.;
- Pathway
- Ether lipid metabolism - Homo sapiens (human);Glycerophospholipid metabolism - Homo sapiens (human);Phosphonate and phosphinate metabolism - Homo sapiens (human);Selenium Micronutrient Network;Selenium Metabolism and Selenoproteins;Metabolism of lipids;Metabolism;Synthesis of PE;phosphatidylethanolamine biosynthesis II;Glycerophospholipid biosynthesis;Phospholipid metabolism
(Consensus)
Intolerance Scores
- loftool
- rvis_EVS
- -0.21
- rvis_percentile_EVS
- 38.58
Haploinsufficiency Scores
- pHI
- hipred
- Y
- hipred_score
- 0.786
- ghis
- 0.578
Essentials
- essential_gene_CRISPR
- essential_gene_CRISPR2
- essential_gene_gene_trap
- K
- gene_indispensability_pred
- gene_indispensability_score
Mouse Genome Informatics
- Gene name
- Selenoi
- Phenotype
Gene ontology
- Biological process
- phosphatidylethanolamine biosynthetic process
- Cellular component
- endoplasmic reticulum membrane;Golgi apparatus;integral component of membrane
- Molecular function
- ethanolaminephosphotransferase activity;phosphotransferase activity, for other substituted phosphate groups;metal ion binding